2060-P: Improving CGM Prescribing through Targeted Outreach and Physician Support Tools for Type 2 Diabetes

Introduction and Objective: Continuous Glucose Monitoring (CGM) is associated with improved glycemic management and overall outcomes among people with diabetes. We tested whether physician education, workflow tools, and patient outreach would increase CGM prescribing and improve A1c outcomes. Methods: Control charts using electronic health record data tracked CGM prescribing and the percentage of adults with an A1c >= 9% with a diagnosis of type 2 diabetes who were seen during the prior two months. Interventions were tracked using PDSA tracking sheets. Results: One upward shift in CGM prescribing for adults with A1c >= 9 was observed within six months, increasing the mean from 21.7% to 39.3%. During the same period, the mean percentage of adults with A1c >= 9 initially rose from 18% to 23.4% then decreased to 19.3%. Conclusion: Patient outreach combined with provider education and workflow tools increased CGM prescribing. Glycemic outcomes may lag as more high-risk people with diabetes engage. Disclosure J. Ginty: None. L.J. Lammert: None. H. Donnelly: None. A. Hintz: None. S. Miller-Branam: None. A. Healy: Consultant; Ended; Novo Nordisk. Speaker's Bureau; Current; Sanofi. S.E. Adkins: None. E.A. Beverly: None. Funding Ohio Department of Medicaid (G-2627-05-0009-ODM/202619)